The IL36RN gene helps put the brakes on inflammation, especially in the skin. If it does not work properly, inflammation can become too active and lead to repeated flares of widespread red skin with small pus-filled bumps, often along with fever and feeling unwell. This pattern is linked to a rare inherited condition called deficiency of the IL-36 receptor antagonist, which can overlap with forms of generalized pustular psoriasis. Most people only hear about the IL36RN gene when genetic testing is done for unexplained severe skin inflammation.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes take place, where they happen, and how active they are. Together, genes affect how the body grows and works, and they can also shape how you respond to food, stress, or medicines. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
IL36RNGene function
What if the gene works
The IL36RN gene makes a protein that helps put the brakes on inflammation. It blocks certain immune signals called IL-36, helping protect skin and other tissues from an overly strong immune response.
Risk
What if the gene does not work
Pathogenic variants in the IL36RN gene can cause repeated episodes of widespread pustular skin inflammation, often with fever and sometimes starting in childhood. Milder or more severe variants may affect when flares begin and how intense they are.
Treatment
What does that mean for your treatment
A pathogenic variant in the IL36RN gene does not currently direct a distinct treatment or drug choice on its own. The IL36RN gene is part of an active drug target pathway, and IL 36 receptor blockers such as spesolimab are used for generalized pustular psoriasis based on the clinical picture rather than IL36RN status.
Conditions associated with IL36RN
Gene function
What if the gene works
In the skin and other body surfaces, the IL36RN gene helps keep inflammation at the right level. It makes a protein that acts like a natural brake on immune messages during everyday irritation, minor injury, or infection. This balance helps control skin inflammation and supports calm, steady healing.
The IL36RN gene makes a protein that blocks certain inflammation signals at a cell's docking site, called a receptor. This helps keep immune responses measured and time limited.
Many skin cells use this protein to stay calm after friction, dryness, or small injuries. It supports the skin barrier by helping limit extra alarm signals.
This gene is especially active in tissues that face the outside world, including the skin and some body linings. It helps these surfaces answer germs and irritation without staying inflamed longer than needed.
After an immune alarm starts, the IL36RN protein helps turn the message down again. This supports a smoother shift from early defense toward recovery and routine tissue maintenance.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human variation, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic diversity. Sometimes, though, a variant changes how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IL36RN gene can change the IL-36 receptor antagonist protein so it is made in smaller amounts, folds poorly, or cannot block inflammatory IL-36 signals well. This is how variants in the IL36RN gene affect the protein at a cellular level. Some changes only partly reduce this blocking effect, while more severe variants can remove it almost completely. That difference can influence how strongly inflammation is switched on and, in IL36RN-related disease, how early and intense flares may be.
How variants are linked to conditions
Pathogenic variants in the IL36RN gene cause a condition called deficiency of the IL-36 receptor antagonist, often shortened to DITRA, and are a well-established genetic cause of generalized pustular psoriasis. In practice, IL36RN gene variants linked to generalized pustular psoriasis are most often found in people with repeated episodes of widespread sterile pustules, fever, and inflamed skin. Some people with changes in this gene are also diagnosed with related pustular psoriasis patterns affecting the hands, feet, or nails.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and occur widely across the population. Most do not directly affect health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with IL36RN changes, the genetic change itself is the main driver of the condition, but flares can be set off by things like infections, stress, and sometimes certain medicines or suddenly stopping steroid treatment. These factors are more about triggering or worsening episodes than changing whether the gene change is present. Early treatment and avoiding known triggers can help limit complications.
Inheritance of IL36RN variants
Variants in the IL36RN gene are inherited in an autosomal recessive pattern. This means a person usually develops IL36RN-related disease only when they inherit one altered copy from each parent. Parents who each carry one IL36RN gene variant are often unaffected themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. This is the usual answer to how IL36RN gene variants are inherited.
What does my IL36RN result mean for my family?
For IL36RN, family impact is usually discussed in a recessive pattern. Brothers and sisters may also have the condition or may carry the same gene change without symptoms, and parents are often healthy carriers. Children of someone with an IL36RN-related condition will usually be carriers, and the chance of them being affected depends on whether the other parent also carries an IL36RN change.
Genetic information
Genetic testing
How you find out about variants
IL36RN genetic testing reads the DNA in the IL36RN gene from a blood or saliva sample. It can check for a known family variant or scan the whole gene, helping show whether a variant linked to IL36RN-related skin inflammation is present.
When should I consider getting a genetic test?
Consider genetic testing for IL36RN if you or your child has repeated attacks of widespread painful, pus-filled skin bumps, often with fever, especially when this starts in childhood or runs in the family. Finding an IL36RN change can help confirm a genetic form of pustular psoriasis and clarify the diagnosis.
A genetic result is only one part of your health story
Genetic test findings can provide useful insight, but what they show depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly or more quickly than another, which can change how well it works or how likely side effects are. These differences are common and help explain why the same treatment can feel very effective for some people but less helpful or harder to tolerate for others.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the IL36RN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work. Questions about treatment, side effects, or other health concerns are best discussed with your doctor.
History
In 2011, researchers identified variants in the IL36RN gene as the cause of a severe inherited inflammatory skin condition now called DITRA, short for deficiency of the IL-36 receptor antagonist. Initially understood through recurring episodes of widespread pustular psoriasis, later recognized as tied to a specific gene, this discovery helped explain why some children and adults developed intense flares with fever and skin inflammation. From these first observations, research expanded steadily. Doctors then found that IL36RN variants could also appear in some people with generalized pustular psoriasis who did not have the full inherited syndrome, which widened clinical interest in the gene. This work marked an important step in linking rare genetic findings with broader inflammatory skin disease.